STI stirling products limited

Overkill, dilution call it whatever you like. Im in for the long...

  1. 594 Posts.
    lightbulb Created with Sketch. 49
    Overkill, dilution call it whatever you like. Im in for the long run as STI has huge potential and a number of projects/ products in the pipeline which take time to bring online, namely the HDA. Who cares if the current SPP dilutes the company shareholding when the potential for Multi-Bill revenue is staring us in the face with the HDA.

    Patience people. I cant think of any other health spec that started from scratch and became great in one day.

    Just remember, the current management has been at the helm for approx 2 years and in that time the (1) Canada plant was picked up at a 20M bargain following the GFC (NTA alone is greater than the current SP)- hence manufacturing for STI/ 3rd party products to begin shortly, (2) the HDA development is progressing on schedule (working prototype already developed and scheduled for delivery to potential customers to test & tweek), (3) Telemedcare acquisition will provide STI with a 20% cut of profits in the first two years, and 40% thereafter. (4) Dont forget Immunoxel - one for the bottom drawer.

    Patience...wise move to load up on 0.005 levels, investors wont be disappointed this time 2012.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.